- |||||||||| olanzapine / Generic mfg., sertraline / Generic mfg.
Trial completion date, Trial primary completion date: STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) - May 1, 2018 P4, N=269, Active, not recruiting, Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018
- |||||||||| Trial completion date, Trial termination, Trial primary completion date: Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia (clinicaltrials.gov) - Apr 27, 2018
P=N/A, N=30, Terminated, Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Trial completion date: Oct 2015 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Mar 2018; Difficulty in financing the research
- |||||||||| Trial completion: A Shared Decision-making Training for Inpatients With Schizophrenia (clinicaltrials.gov) - Apr 25, 2018
P=N/A, N=264, Completed, Trial completion date: Oct 2015 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Mar 2018; Difficulty in financing the research Active, not recruiting --> Completed
- |||||||||| Trial completion date, Trial primary completion date: Social Cognition Training in Schizophrenia (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=25, Recruiting, Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Trial completion date: Jan 2018 --> Dec 2018 | Trial primary completion date: Jan 2018 --> Jun 2018
- |||||||||| Trial completion, Trial primary completion date: Very Low Nicotine Cigarettes in Smokers With Schizophrenia (clinicaltrials.gov) - Apr 9, 2018
P2, N=58, Completed, Trial completion date: Jan 2018 --> Dec 2018 | Trial primary completion date: Jan 2018 --> Jun 2018 Recruiting --> Completed | Trial primary completion date: Aug 2018 --> Aug 2017
- |||||||||| Phase classification, Enrollment change: Brain Circuits in Schizophrenia and Smoking (clinicaltrials.gov) - Apr 6, 2018
P, N=42, Completed, Phase classification: P=N/A --> P Phase classification: P=N/A --> P | N=300 --> 42
- |||||||||| Trial completion, Trial completion date: Feeling of Being in Control of One's Own Action (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=198, Completed, Recruiting --> Completed | N=36 --> 16 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017
- |||||||||| Arvisol (cannabidiol) / Echo Pharma
Trial completion, Preclinical, Trial completion date, Trial primary completion date: CBD-IS: Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (clinicaltrials.gov) - Mar 8, 2018 P1, N=74, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017 Recruiting --> Completed | Trial completion date: Apr 2017 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Aug 2017
- |||||||||| sodium valproate / Generic mfg.
Trial completion, Trial completion date, Trial initiation date, Trial primary completion date: Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia (clinicaltrials.gov) - Feb 14, 2018 P4, N=109, Completed, Recruiting --> Completed | Trial completion date: Apr 2017 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Aug 2017 Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017 | Initiation date: Mar 2013 --> Apr 2013 | Trial primary completion date: Oct 2017 --> Oct 2017
- |||||||||| Trial completion, Phase classification: EmeraldThunder: rTMS in First Episode Psychosis (clinicaltrials.gov) - Feb 14, 2018
P=N/A, N=20, Completed, Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017 | Initiation date: Mar 2013 --> Apr 2013 | Trial primary completion date: Oct 2017 --> Oct 2017 Recruiting --> Completed | Phase classification: P2 --> PN/A
- |||||||||| aripiprazole / Generic mfg., olanzapine / Generic mfg.
Trial completion, Phase classification, Trial completion date, Trial primary completion date, Adverse events: Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic (clinicaltrials.gov) - Feb 6, 2018 P=N/A, N=200, Completed, Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: May 2016 --> May 2017 | Trial completion date: Nov 2016 --> Jul 2017
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Cognitive Remediation and Sheltered Employment in Schizophrenia (clinicaltrials.gov) - Jan 31, 2018
P=N/A, N=79, Active, not recruiting, Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: May 2016 --> May 2017 | Trial completion date: Nov 2016 --> Jul 2017 Recruiting --> Active, not recruiting | N=260 --> 79 | Trial primary completion date: May 2018 --> Sep 2018
- |||||||||| olanzapine / Generic mfg., sertraline / Generic mfg.
Trial primary completion date: STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) - Nov 9, 2017 P4, N=269, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> May 2017 Trial primary completion date: Aug 2017 --> Mar 2018
- |||||||||| Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: SPA: A System for Preference Assessment in Mental Health (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=61, Completed, Trial primary completion date: Aug 2017 --> Mar 2018 Recruiting --> Completed | N=90 --> 61 | Initiation date: Jan 2016 --> Jun 2014 | Trial primary completion date: Jul 2017 --> Oct 2017
- |||||||||| Trial completion, Trial primary completion date: The Partners Genetics Collaborative Study of Schizophrenia (clinicaltrials.gov) - Oct 20, 2017
P=N/A, N=451, Completed, Trial primary completion date: Jun 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Oct 2017
- |||||||||| Trial primary completion date: Fingolimod in Schizophrenia Patients (clinicaltrials.gov) - Oct 11, 2017
P2, N=40, Active, not recruiting, Recruiting --> Completed Trial primary completion date: Aug 2017 --> Dec 2017
- |||||||||| Trial completion, Enrollment change: Testing Effect and Schizophrenia (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=40, Completed, Completed --> Terminated Recruiting --> Completed | N=50 --> 40
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Feeling of Being in Control of One's Own Action (clinicaltrials.gov) - Oct 5, 2017
P=N/A, N=200, Active, not recruiting, Recruiting --> Completed | N=228 --> 126 | Trial primary completion date: Dec 2017 --> Apr 2012 Recruiting --> Active, not recruiting | N=370 --> 200 | Trial primary completion date: Dec 2017 --> Jun 2017
- |||||||||| Trial completion, Phase classification, Trial initiation date, Trial primary completion date: DCS: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (clinicaltrials.gov) - Sep 19, 2017
P, N=2, Completed, Recruiting --> Completed Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Jul 2017 --> Sep 2016
|